**Core Concept**
The question is testing the student's knowledge of radionuclide imaging in assessing renal function. Radionuclide imaging involves the use of radioactive materials to visualize and assess organ function. In the context of renal function, the radionuclide of choice should be one that is excreted by the kidneys in a manner that reflects their function.

**Why the Correct Answer is Right**
The correct answer is Tc-99m MAG3, a radiopharmaceutical that is specifically excreted by the kidneys through the tubular secretion mechanism. This makes it an ideal choice for assessing renal function, particularly in patients with impaired glomerular filtration rate (GFR). Tc-99m MAG3 is taken up by the renal tubules and is then excreted into the urine, allowing for the measurement of renal function. The use of Tc-99m MAG3 also allows for the assessment of renal vasculature and the detection of any obstruction in the urinary tract.

**Why Each Wrong Option is Incorrect**
**Option A:** Tc-99m DTPA is a radiopharmaceutical that is excreted by the kidneys primarily through glomerular filtration. While it is useful for assessing renal function, it is not as sensitive as Tc-99m MAG3 in patients with impaired GFR.
**Option B:** I-131 OIH is a radiopharmaceutical that is primarily used for imaging the liver and spleen, rather than the kidneys.
**Option C:** Ga-67 citrate is a radiopharmaceutical that is primarily used for imaging the liver, spleen, and bone marrow, rather than the kidneys.

**Clinical Pearl / High-Yield Fact**
When choosing a radionuclide for assessing renal function, it's essential to consider the mechanism of excretion and the sensitivity of the test in patients with impaired GFR. Tc-99m MAG3 is a more sensitive and specific choice than Tc-99m DTPA, particularly in patients with renal impairment.

**Correct Answer:** C. Ga-67 citrate